[{"address1": "100 Campus Drive", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "608 441 8120", "website": "https://www.cellectar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Mr. James V. Caruso", "age": 64, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 1142418, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chad J. Kolean CPA", "age": 59, "title": "VP, CFO & Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 711230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jarrod  Longcor", "age": 50, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 854242, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Darrell Shane Lea", "age": 49, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrei  Shustov M.D.", "age": 51, "title": "Senior Vice President of Medical", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.01, "open": 2.01, "dayLow": 1.83, "dayHigh": 2.02, "regularMarketPreviousClose": 2.01, "regularMarketOpen": 2.01, "regularMarketDayLow": 1.83, "regularMarketDayHigh": 2.02, "beta": 1.007, "forwardPE": -3.4658167, "volume": 1215005, "regularMarketVolume": 1215005, "averageVolume": 252285, "averageVolume10days": 359900, "averageDailyVolume10Day": 359900, "bid": 1.84, "ask": 1.9, "bidSize": 100, "askSize": 100, "marketCap": 75453688, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 4.45, "fiftyDayAverage": 2.0746, "twoHundredDayAverage": 2.7828, "currency": "USD", "enterpriseValue": 59341328, "floatShares": 29602617, "sharesOutstanding": 40566500, "sharesShort": 1835227, "sharesShortPriorMonth": 2203374, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0452, "heldPercentInsiders": 0.02839, "heldPercentInstitutions": 0.34549, "shortRatio": 8.34, "shortPercentOfFloat": 0.0506, "impliedSharesOutstanding": 41537000, "bookValue": 0.127, "priceToBook": 14.645669, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -52962856, "trailingEps": -2.43, "forwardEps": -2.83, "lastSplitFactor": "1:10", "lastSplitDate": 1658448000, "enterpriseToEbitda": -1.252, "52WeekChange": -0.1388889, "SandP52WeekChange": 0.29098952, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CLRB", "underlyingSymbol": "CLRB", "shortName": "Cellectar Biosciences, Inc.", "longName": "Cellectar Biosciences, Inc.", "firstTradeDateEpochUtc": 1131633000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d92a6d57-8c29-3e38-89dc-584b57cac7f0", "messageBoardId": "finmb_37613299", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.86, "targetHighPrice": 28.0, "targetLowPrice": 7.0, "targetMeanPrice": 16.33333, "targetMedianPrice": 14.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 25868908, "totalCashPerShare": 0.638, "ebitda": -47400856, "totalDebt": 530856, "quickRatio": 1.705, "currentRatio": 1.84, "debtToEquity": 3.857, "returnOnAssets": -1.65998, "returnOnEquity": -7.96674, "freeCashflow": -20477556, "operatingCashflow": -45166224, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-16"}]